Moderna faces significant uncertainty ahead of Q3 earnings, with heavy reliance on COVID vaccine revenues and limited ...

CureVac's (CVAC) mRNA innovations, strong patent portfolio, and investment potential. Learn the risks and rewards of this biotech stock.

AstraZeneca and Oxford University's potential COVID-19 vaccine produced a strong immune response in older adults, data published on Thursday showed, with researchers expecting to release late-stage ...

Moderna Inc said on Monday it has applied for U.S. emergency authorization for its COVID-19 vaccine after full results from a late-stage study showed it was 94.1% effective with no serious safety ...

A Florida pharmacy licensing board on Tuesday made clear that prescriptions aren’t necessary for patients who want to get vaccinated against COVID-19. During a brief meeting that included no public ...

New vaccine shows promise in curing deadly allergies, scientists say - Researchers say vaccine prevents allergens from triggering deadly immune reactions in mice ...

Analyses of RNA expression reveal molecules underpinning the cancer-associated process of skeletal-muscle wasting, a ...

Washington — Pfizer has agreed to offer significantly discounted prices for some prescription drugs for all American consumers and has committed to offer prescription medications to Medicaid at lower ...

Pfizer has thrown money at its obesity R&D problem. Having seen its internal assets flounder, the Big Pharma has struck a deal to buy Metsera for an initial $4.9 billion to secure a pipeline of ...

Pfizer agreed to buy the obesity startup Metsera for an enterprise value of about $4.9 billion as it seeks to catch up in a booming market after terminating the development of its own weight-loss pill ...

GoodRx reports that CDC now recommends COVID-19 vaccinations be decided with healthcare professionals, stressing personalized ...

Pfizer agrees to lower prescription drug costs for Medicaid in a deal with Trump WASHINGTON (AP) — Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the ...